$KODK

Kodak’s Transformed Business Has Improved for Four Straight Quarters

Eastman Kodak reported FY2026 Q2 revenue of $311 million, up $48 million year over year, and gross profit up $31 million (61%). GAAP net income was $17 million versus a $26 million net loss a year earlier. Kodak attributed the $43 million improvement to higher gross profit, lower interest expense and fewer impairments. Print revenue was $195 million; Advanced Materials and Chemicals $105 million.

Original reporting
Published Aug 13, 2026, 7:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 8:08 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Kodak’s Transformed Business Has Improved for Four Straight Quarters — source image
Decision brief

The 30-second read

$KODKBullishMed
01

Why it matters

The article highlights a profitability swing and sustained YoY improvement across four quarters, attributing gains to gross profit improvement, reduced interest expense, and lower impairments, partially offset by lower pension income.

02

Market read

Traders can reassess Kodak’s turnaround trajectory using the reported Q2 financial improvements, but lack of explicit forward guidance limits conviction.

03

What to watch

The article does not provide segment-level profitability, cash flow, or explicit forward guidance, so traders may discount the sustainability of the turnaround.

Relevance 7/10Novelty 6/10Timing: after-hours or same-day read-through of FY2026 Q2 results

Background

Kodak’s transformation narrative is framed against last year’s uncertainty and a pension-plan termination plan to address about $477M of debt.

Company-level read

Ticker impact

$KODKBullishMedium confidence
Context

Kodak reports FY2026 Q2 revenue of $311M, up $48M YoY, with GAAP net income turning to $17M and gross profit up 61%.

Expected impact

Near-term upside bias versus prior expectations, with follow-through dependent on subsequent quarter execution.

Evidence & confidence

The text includes concrete financial datapoints (revenue, gross profit, net income) and cites drivers (gross profit, lower interest, lower impairments) plus ongoing transformation and R&D/infrastructure investment.

Market effects

Supports sentiment for turnaround industrials and specialty materials tied to imaging and advanced materials demand.

Limited regional spillover; primarily company-specific sentiment for Rochester-area industrial/legacy manufacturing perception.

Modest global relevance given Kodak’s niche exposure, but film and advanced materials demand can influence niche supply chains.

Counterpoint

Improvement may be partly accounting-driven (interest expense, impairments, pension effects) rather than durable operating demand growth.

Key entities

  • Eastman Kodak

    Reports FY2026 Q2 revenue, gross profit, and GAAP net income improvement, citing progress in its transformation plan.

  • Jim Continenza

    Executive Chairman and CEO quoted on stability, growth, and the next phase of Kodak’s transformation.

  • Kodak pension plan termination

    Previously discussed plan to terminate the pension plan and receive about $500M of assets upon closing in December 2025.

Related articles

$SNDKMedAI 8/10

Sandisk Just Made the Next Memory Crash a Lot Less Scary

Sandisk (SNDK) reported $6.9B net income in Q1, driven by high memory prices. The company has 10 long-term supply agreements worth at least $93.9B, providing downside protection. Revenue grew 175% YoY to $20.25B in fiscal 2026. Management expects over half of fiscal 2027 volumes to be covered by these agreements, with attractive margins even at floor pricing.

$EHCHighAI 8/10

Encompass Health (EHC): This Rehab Hospital Giant Just Raised Its Own Bar Again

Encompass Health (EHC) reported Q2 revenue of $1.597B, up 9.6%, and adjusted EPS of $1.55, up 10.7%. The company raised full-year guidance for revenue, EBITDA, and EPS. It also increased its stock repurchase authorization to $1B. Patient volume and revenue per discharge grew, but free cash flow fell due to higher capital spending. Long-term debt rose to $2.598B.

$TOLMedAI 8/10

Toll Brothers (TOL) Keeps Building Contracts As Profits Take A Hit

Toll Brothers (TOL) reported Q3 earnings with net income down to $280.1M ($2.97 per share) from $369.6M ($3.73) year-over-year. Net signed contracts rose to $2.52B from $2.41B. The company increased its share buyback plan to $700M and maintained full-year guidance. Home sales revenue is expected to be around $10.5B with a 26.1% adjusted gross margin.

$LMedAI 8/10

Loews (L) Grows Profit And Book Value, But Underwriting Slips

Loews (L) reported Q2 2026 net income of $444M ($2.16/Share), up from $391M ($1.87/Share) in Q2 2025. Book value per share rose to $93.52. CNA Financial (CNA), its largest unit, saw net income increase to $294M. Boardwalk Pipelines and Loews Hotels also reported higher profits. However, CNA's underwriting margins slipped, with the combined ratio widening to 96.5%.